How is European patent law addressing the growing use of artificial intelligence in pharmaceutical innovation?

Our Paolo Di Giovine shares analysis and thoughts in his new article, “Patentability of AI-based Inventions in the Pharmaceutical Field under European Patent Law”, just published in the European Health & Pharmaceutical Law Review.

AI is increasingly shaping pharmaceutical R&D, and a full understanding of what this can mean in terms of patent protection is becoming essential for both innovators and legal practitioners.

Paolo explores key questions around inventorship, technical character and patent eligibility, and he reflects on whether the current legal framework is adequate to accommodate AI-driven inventions in this rapidly evolving field.

Read the abstract on EHPL website (payment required for full text).